Status:
COMPLETED
Pharmacokinetics of Faldaprevir of Soft Capsule
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The aim of the trial is to assess the bioavailability of Faldaprevir soft capsule with single oral dose and multiple oral doses in Chinese subjects
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy male and female subjects
- Exclusion criteria:
- Any relevant deviation from healthy conditionsAny relevant deviation from healthy conditions
Exclusion
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01821937
Start Date
March 1 2013
End Date
May 1 2013
Last Update
August 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1220.52.86001 Boehringer Ingelheim Investigational Site
Beijing, China